Published in Mol Pharmacol on October 01, 1999
Flavonoids as aryl hydrocarbon receptor agonists/antagonists: effects of structure and cell context. Environ Health Perspect (2003) 2.32
Inhibition of mitochondrial proton F0F1-ATPase/ATP synthase by polyphenolic phytochemicals. Br J Pharmacol (2000) 1.94
Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention. BMC Cancer (2009) 1.31
Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challenges. Curr Cancer Drug Targets (2012) 1.23
Methoxylated flavones, a superior cancer chemopreventive flavonoid subclass? Semin Cancer Biol (2007) 1.15
Problems for risk assessment of endocrine-active estrogenic compounds. Environ Health Perspect (2002) 1.11
Subchronic oral toxicity and cardiovascular safety pharmacology studies of resveratrol, a naturally occurring polyphenol with cancer preventive activity. Food Chem Toxicol (2011) 1.03
Resveratrol inhibits dioxin-induced expression of human CYP1A1 and CYP1B1 by inhibiting recruitment of the aryl hydrocarbon receptor complex and RNA polymerase II to the regulatory regions of the corresponding genes. Toxicol Sci (2009) 1.03
Phytoestrogens and breast cancer prevention: possible mechanisms of action. Environ Health Perspect (2008) 1.02
Resveratrol, through NF-Y/p53/Sin3/HDAC1 complex phosphorylation, inhibits estrogen receptor alpha gene expression via p38MAPK/CK2 signaling in human breast cancer cells. FASEB J (2011) 0.96
Herb-drug interactions: challenges and opportunities for improved predictions. Drug Metab Dispos (2013) 0.94
Grape seed proanthocyanidin suppression of breast cell carcinogenesis induced by chronic exposure to combined 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and benzo[a]pyrene. Mol Carcinog (2010) 0.94
Ligand-dependent interactions of the Ah receptor with coactivators in a mammalian two-hybrid assay. Toxicol Appl Pharmacol (2007) 0.92
Preferential induction of cytochrome P450 1A1 over cytochrome P450 1B1 in human breast epithelial cells following exposure to quercetin. J Steroid Biochem Mol Biol (2008) 0.88
Analysis of resveratrol as a lung cancer chemopreventive agent in A/J mice exposed to benzo[a]pyrene. Br J Cancer (2004) 0.88
Oncogenicity evaluation of resveratrol in p53(+/-) (p53 knockout) mice. Food Chem Toxicol (2006) 0.85
Chlorophyllin significantly reduces benzo[a]pyrene-DNA adduct formation and alters cytochrome P450 1A1 and 1B1 expression and EROD activity in normal human mammary epithelial cells. Environ Mol Mutagen (2009) 0.85
Resveratrol inhibits benzo[a]pyrene-DNA adduct formation in human bronchial epithelial cells. Br J Cancer (2004) 0.83
Differential Effects of Glycyrrhiza Species on Genotoxic Estrogen Metabolism: Licochalcone A Downregulates P450 1B1, whereas Isoliquiritigenin Stimulates It. Chem Res Toxicol (2015) 0.80
Resveratrol potentiates effects of simvastatin on inhibition of rat ovarian theca-interstitial cells steroidogenesis. J Ovarian Res (2014) 0.79
Estrogen receptor expression is required for low-dose resveratrol-mediated repression of aryl hydrocarbon receptor activity. J Pharmacol Exp Ther (2010) 0.79
Antitumour activity of the novel flavonoid Oncamex in preclinical breast cancer models. Br J Cancer (2016) 0.77
Correlation between CYP1A1 transcript, protein level, enzyme activity and DNA adduct formation in normal human mammary epithelial cell strains exposed to benzo[a]pyrene. Mutagenesis (2014) 0.75
Paternal smoking and germ cell death: A mechanistic link to the effects of cigarette smoke on spermatogenesis and possible long-term sequelae in offspring. Mol Cell Endocrinol (2016) 0.75
Effects of resveratrol on drug- and carcinogen-metabolizing enzymes, implications for cancer prevention. Pharmacol Res Perspect (2017) 0.75
Neutrophils employ the myeloperoxidase system to generate antimicrobial brominating and chlorinating oxidants during sepsis. Proc Natl Acad Sci U S A (2001) 1.84
Characterization of collagen gel solutions and collagen matrices for cell culture. Biomaterials (2001) 1.44
Dietary flavonols quercetin and kaempferol are ligands of the aryl hydrocarbon receptor that affect CYP1A1 transcription differentially. Biochem J (1999) 1.42
Resveratrol inhibits transcription of CYP1A1 in vitro by preventing activation of the aryl hydrocarbon receptor. Cancer Res (1998) 1.32
Evidence for direct inhibition of de novo purine synthesis in human MCF-7 breast cells as a principal mode of metabolic inhibition by methotrexate. J Biol Chem (1987) 1.19
Increased AP-1 activity in drug resistant human breast cancer MCF-7 cells. Breast Cancer Res Treat (1999) 1.12
Effect of curcumin on the aryl hydrocarbon receptor and cytochrome P450 1A1 in MCF-7 human breast carcinoma cells. Biochem Pharmacol (1998) 1.10
Induction of thymidylate synthase associated with multidrug resistance in human breast and colon cancer cell lines. Mol Pharmacol (1991) 1.03
Modulation of angiogenesis by dithiolethione-modified NSAIDs and valproic acid. Br J Pharmacol (2007) 1.03
Modulation of adriamycin accumulation and efflux by flavonoids in HCT-15 colon cells. Activation of P-glycoprotein as a putative mechanism. Biochem Pharmacol (1994) 0.97
Purified human erythrocyte pyrroline-5-carboxylate reductase. Preferential oxidation of NADPH. J Biol Chem (1989) 0.97
The effect of pyrroline-5-carboxylic acid on nucleotide metabolism in erythrocytes from normal and glucose-6-phosphate dehydrogenase-deficient subjects. J Biol Chem (1984) 0.96
Stimulation of the hexosemonophosphate-pentose pathway by pyrroline-5-carboxylate in cultured cells. J Cell Physiol (1982) 0.96
The function of pyrroline-5-carboxylate reductase in human erythrocytes. Biochem Biophys Res Commun (1980) 0.95
DNA damage and cell cycle arrest induced by 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole (5F 203, NSC 703786) is attenuated in aryl hydrocarbon receptor deficient MCF-7 cells. Br J Cancer (2003) 0.94
Transfer of 1-pyrroline-5-carboxylate as oxidizing potential from hepatocytes to erythrocytes. Biochem J (1982) 0.93
Pyrroline-5-carboxylate reductase in human erythrocytes. J Clin Invest (1981) 0.92
Diosmin and diosmetin are agonists of the aryl hydrocarbon receptor that differentially affect cytochrome P450 1A1 activity. Cancer Res (1998) 0.92
Inhibition of P-glycoprotein activity and reversal of multidrug resistance in vitro by rosemary extract. Eur J Cancer (1999) 0.91
Cyclooxygenase-2, P-glycoprotein-170 and drug resistance; is chemoprevention against multidrug resistance possible? Anticancer Res (2001) 0.90
The flavonoid galangin is an inhibitor of CYP1A1 activity and an agonist/antagonist of the aryl hydrocarbon receptor. Br J Cancer (1999) 0.90
The stimulation of purine nucleotide production by pyrroline-5-carboxylic acid in human erythrocytes. Biochem Biophys Res Commun (1981) 0.89
Co-administration of dextromethorphan during pregnancy and throughout lactation significantly decreases the adverse effects associated with chronic morphine administration in rat offspring. Life Sci (2001) 0.88
Flavonol-stimulated efflux of 7,12-dimethylbenz(a)anthracene in multidrug-resistant breast cancer cells. Cancer Res (1993) 0.88
Kindling induces the long-lasting expression of a novel population of NMDA receptors in hippocampal region CA3. J Neurosci (1994) 0.87
Development of a high-performance liquid chromatographic method for bioequivalence study of flavoxate tablets. J Chromatogr B Biomed Sci Appl (2001) 0.86
Accumulation of fatty alcohol in MCF-7 breast cancer cells. Arch Biochem Biophys (1994) 0.86
Glycine regulation of the N-methyl-D-aspartate receptor-gated ion channel in hippocampal membranes. Mol Pharmacol (1989) 0.85
Linkage of the HMP pathway to ATP generation by the proline cycle. Biochem Biophys Res Commun (1980) 0.85
Dibenzoylmethane modulates aryl hydrocarbon receptor function and expression of cytochromes P50 1A1, 1A2, and 1B1. Cancer Res (2001) 0.83
The steroid hormone dehydroepiandrosterone inhibits CYP1A1 expression in vitro by a post-transcriptional mechanism. J Biol Chem (1999) 0.82
Differential expression and activity of phosphatases and protein kinases in adriamycin sensitive and resistant human breast cancer MCF-7 cells. Int J Oncol (1998) 0.81
Stimulation of the hexose-monophosphate pentose pathway by delta 1-pyrroline-5-carboxylic acid in human fibroblasts. Biochem Biophys Res Commun (1979) 0.81
The effects of resveratrol on CYP1A1 expression and aryl hydrocarbon receptor function in vitro. Adv Exp Med Biol (2001) 0.79
Pulsed radiofrequency inhibited activation of spinal mitogen-activated protein kinases and ameliorated early neuropathic pain in rats. Eur J Pain (2014) 0.79
Thymus size and its relationship to perinatal events. Acta Paediatr (2000) 0.78
The intercellular proline cycle. Life Sci (1981) 0.78
Antimetabolites. Cancer Chemother Biol Response Modif (1991) 0.77
Development of a high-performance liquid chromatographic method for bioanalytical applications with sulpiride. J Chromatogr B Biomed Sci Appl (2001) 0.77
Sequential up-regulation of the c-fos, c-jun and bax genes in the cortex, striatum and cerebellum induced by a single injection of a low dose of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in C57BL/6 mice. Neurosci Lett (2001) 0.77
Trends in the epidemiology, diagnosed age and mortality rate of haemophiliacs in Taiwan: a population-based study, 1997-2009. Haemophilia (2014) 0.77
Altered bone development in a mouse model of peripheral sensory nerve inactivation. J Musculoskelet Neuronal Interact (2014) 0.76
Increased phospholipase D activity in multidrug resistant breast cancer cells. Biochem Biophys Res Commun (1994) 0.76
Pyrroline-5-carboxylate stimulates the conversion of purine antimetabolites to their nucleotide forms by a redox-dependent mechanism. J Biol Chem (1983) 0.76
Unique coronary vasodilator induction by leukotriene D4. Am J Physiol (1985) 0.75
Antimetabolites. Cancer Chemother Biol Response Modif (1987) 0.75
Antimetabolites. Cancer Chemother Biol Response Modif (1988) 0.75
Antimetabolites. Cancer Chemother Biol Response Modif (1990) 0.75